Evidence map›Paper›PMID 31482025›Full record

ArticleCentral European journal of urology2019

Outcomes of mini-percutaneous nephrolithotomies in children: a single centre experience.

Abdülkadir Kandemir, Mehmet Balasar, Mehmet Mesut Pişkin, Ahmet Öztürk

Open access · greenAbstract read
In one paragraph

Article in Central European journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Abdülkadir KandemirDepartment of Urology, Kelkit State Hospital, Kelkit, Turkey.
Mehmet BalasarDepartment of Urology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey.
Mehmet Mesut PişkinDepartment of Urology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey.
Ahmet ÖztürkDepartment of Urology, Necmettin Erbakan University, Meram Medical Faculty, Konya, Turkey.
Necmettin Erbakan University · TRSivas State Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to present to present our experiences with pediatric mini-percutaneous nephrolithotomies (MPNL) in our center. MATERIAL AND

methodsA total of 85 MPNLs performed on 79 pediatric patients being treated for upper urinary tract stones from 2007 to 2017 were analyzed retrospectively in order to determine their safety, efficacy, and relevant outcomes.

results85 MPNLs performed on 79 patients with a mean age of 6.58 (1-14) years were included in this study. The mean size of the stones was 1.99 (1-6.4) mm. A 17 Fr rigid pediatric nephroscope with a pneumatic intracorporeal lithotripsy was used through a 20 Fr access sheath. The stone-free rate was 87.1% at 1 month postoperatively. Mean operative time was 56.4 (20-120) min. Mean fluoroscopy screening time was 183.2 (40-510) sec. Average hospitalization duration was 4.78 (2-13) days. Auxiliary procedures were performed on 7 (8.2%) patients (5 extracorporeal shock wave lithotripsy, 2 re- percutaneous nephrolithotomy). The complication rate of these cases was 6.3% according to the modified Clavien Classification System. However, no major complications classified as Clavien IV-V were observed in the study group.

conclusionsThe outcomes of the contemporary analysis confirm that MNPL is a safe and efficient method of intervention resulting in a stone-free state in pediatric cases.

Indexed as

childrencomplicationmini-PNLrenal stone

Identifiers

PMID31482025
PMCPMC6715085
OpenAlexW3015344323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.